WHO convened a scoping consultation on severe bacterial infections in advanced HIV disease, consulting with academics, program managers and civil society representatives. Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and reduce mortality. The purpose of the meeting was to
- Review the current research and implementation data on the use of prophylactic antibiotics (specifically azithromycin/macrolides) as part of the AHD package of care
- To review options for preventing SBIs that are in line with goals of reducing AMR
- Present the current evidence on diagnostics for SBI
- Discuss research gaps and implementation challenges.
Entire content available on: https://www.who.int/publications-detail-redirect/9789240049703
Lingua
IngleseTipologia
RapportiArgomento
Resistenza Antimicrobica (AMR) HIV Malattie infettiveProfilo
Ospedale/LTCF Salute pubblica Cure primariePaese
USA Canada America del sud America centrale Caraibi Medio oriente Sud Pacifico Cina India Indocina Singapore Europa e UK Oceania Africa